RIFAXIA-200 TABLETS
RIFAXIA-200 TABLETS
Product Details :
| Feature | Details |
|---|---|
| Product Name | RIFAXIA-200 Tablets |
| Form | Tablets |
| Key Ingredient | Rifaximin 200 mg |
| Core Benefits | Treats traveler’s diarrhea, SIBO, IBS-D, hepatic encephalopathy |
| Mechanism of Action | Inhibits bacterial RNA synthesis locally in the gut |
| Support Areas | Digestive health, gut infections, liver-related cognitive issues |
| Recommended Usage | 1 tablet 2–3 times daily or as directed by a physician |
| Target Audience | Adults and adolescents with GI disturbances |
Composition: Rifaximin 200mg Packing: 10X10 Alu-Alu
Description : RIFAXIA-200 Tablets contain Rifaximin 200 mg, a gut-specific, broad-spectrum antibiotic used to treat traveler’s diarrhea, small intestinal bacterial overgrowth (SIBO), and certain gastrointestinal infections caused by non-invasive strains of E. coli. It acts locally in the intestines without significant absorption into the bloodstream, minimizing systemic side effects. RIFAXIA-200 is also used in managing hepatic encephalopathy and IBS-D. Well-tolerated and effective, it helps restore gut balance and control symptoms, especially under the supervision of a healthcare professional.